Defymed's mission is to develop innovative medical devices for diabetic patients providing effective treatments and improving quality of life
million diabetics worldwide forecasted for 2045
billion per year spent on diabetes-related expenses
more than 10
million diabetics receiving insulin therapy have poorly regulated blood glucose levels
May 05 2022
12-13 May: Defymed at the Meet2Win convention Our president Séverine SIGRIST will be present at the...
April 20 2022
Press release Strasbourg and Angers, 20th April 2022 Defymed and GlioC...